Answers are grounded in this paper and cite their sources.
Articles in Press, Accepted Manuscript, Available Online from 01 October 2026 https://doi.org/10.22034/ijp.2026.2081616.3610 Samaneh Faraji Hajibaba, Armin Bakhshipour Roudsari, Alireza Motamedi, Behrooz Shokouhi Gogani, Sahar Rezaei, Tala Pourlak Abstract Background & Objective: Differentiating follicular adenoma (FA) from the follicular variant of papillary thyroid carcinoma (FVPTC) is challenging because of overlapping follicular architecture and subtle nuclear features. Immunohistochemical markers such as HBME-1, CK19, and CD56 have been proposed as adjuncts to histopathology to improve diagnostic confidence. This study evaluated the expression of these markers in FVPTC and FA in a single-center Iranian cohort. Methods: In this retrospective cross-sectional study, 40 thyroid resections (20 FA, 20 FVPTC) diagnosed between 2021 and 2023 at Imam Reza Hospital (Tabriz, Iran) were analyzed. Formalin-fixed, paraffin-embedded sections were immunostained for HBME-1, CK19, and CD56. Two pathologists, blinded to the final diagnosis, independently scored staining as positive or negative using a >10% tumor cell cutoff. Demographic data and histologic invasion features were recorded. Group differences were evaluated with Welch’s two-sample t test for continuous variables and Fisher exact test for categorical variables (P < 0.05). AUC values were calculated for each marker to assess diagnostic performance. Results: The FVPTC and FA groups were comparable in age (50.35 ± 6.60 vs. 49.52 ± 8.29 years; P = 0.728) and sex distribution (60.0% vs. 55.0% female; P = 1.000). Retained CD56 expression was more frequent in FA than in FVPTC (70.0% vs. 20.0%; P = 0.004), whereas CK19 and HBME-1 positivity were more frequent in FVPTC than in FA (95.0% vs. 55.0%, P = 0.008, and 90.0% vs. 30.0%, P < 0.001, respectively). Vascular, capsular, and perineural invasion occurred exclusively in FVPTC (70.0%, 50.0%, and 40.0%, respectively; P < 0.001, P < 0.001, and P = 0.003). HBME-1 showed the highest AUC (0.800), followed by loss of CD56 expression (0.750) and CK19 (0.700). Conclusion: HBME-1 and CK19 positivity and loss of CD56 expression were more frequently observed in FVPTC than in FA, whereas retained CD56 expression was more common in FA. These markers may be useful adjuncts to careful histopathologic evaluation of follicular-patterned thyroid lesions, but they should not be used in isolation for diagnostic or clinical decision-making. Larger multicenter studies applying current WHO criteria and integrating molecular testing are needed to validate these findings.
No takes yet. Share an insight, caveat, or question.
Heidarpour et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: